Screening of potential biomarkers in peripheral blood of patients with depression based on weighted gene co-expression network analysis and machine learning algorithms

Abstract

BackgroundThe prevalence of depression has been increasing worldwide in recent years, posing a heavy burden on patients and society. However, the diagnostic and therapeutic tools available for this disease are inadequate. Therefore, this research focused on the identification of potential biomarkers in the peripheral blood of patients with depression.MethodsThe expression dataset GSE98793 of depression was provided by the Gene Expression Omnibus (GEO) (https://www.ncbi.nlm.nih.gov/gds). Initially, differentially expressed genes (DEGs) were detected in GSE98793. Subsequently, the most relevant modules for depression were screened according to weighted gene co-expression network analysis (WGCNA). Finally, the identified DEGs were mapped to the WGCNA module genes to obtain the intersection genes. In addition, Gene Ontology (GO), Disease Ontology (DO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analyses were conducted on these genes. Moreover, biomarker screening was carried out by protein-protein interaction (PPI) network construction of intersection genes on the basis of various machine learning algorithms. Furthermore, the gene set enrichment analysis (GSEA), immune function analysis, transcription factor (TF) analysis, and the prediction of the regulatory mechanism were collectively performed on the identified biomarkers. In addition, we also estimated the clinical diagnostic ability of the obtained biomarkers, and performed Mfuzz expression pattern clustering and functional enrichment of the most potential biomarkers to explore their regulatory mechanisms. Finally, we also perform biomarker-related drug prediction.ResultsDifferential analysis was used for obtaining a total of 550 DEGs and WGCNA for obtaining 1,194 significant genes. Intersection analysis of the two yielded 140 intersection genes. Biological functional analysis indicated that these genes had a major role in inflammation-related bacterial infection pathways and cardiovascular diseases such as atherosclerosis. Subsequently, the genes S100A12, SERPINB2, TIGIT, GRB10, and LHFPL2 in peripheral serum were identified as depression biomarkers by using machine learning algorithms. Among them, S100A12 is the most valuable biomarker for clinical diagnosis. Finally, antidepressants, including disodium selenite and eplerenone, were predicted.ConclusionThe genes S100A12, TIGIT, SERPINB2, GRB10, and LHFPL2 in peripheral serum are viable diagnostic biomarkers for depression. and contribute to the diagnosis and prevention of depression in clinical practice.

Actin filament‐associated protein 1‐antisense RNA1 promotes the development and invasion of tongue squamous cell carcinoma via the AFAP1‐AS1/miR‐133a‐5p/ZIC2 axis

“…The Mfuzz package 29 was used in the study to cluster the Mfuzz expression pattern based on AFAP1‐AS1 expression levels, and the single sample GSEA (ssGSEA) scores of various clustering modules and TSCC groups were calculated. The correlation between the clustering module and AFAP1‐AS1 was calculated, and the gene module most closely linked to AFAP1‐AS1 was determined.…”

SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN

“…Gene set enrichment analysis (GSEA) was performed based on the TCGA-PAAD and HALLMARK databases to investigate the biological functions and potential signaling pathways of survival-related biomarkers 59 . They were considered significantly enriched if the false discovery rate was < 0.25, P -value was < 0.05, and |LogFC| was > 0.2.…”

Psychiatric Psychobiological Treatment Versus Exclusive Psychological Treatment in Depressive Disorders

“…There is still no conclusive data on genetic links and depression. However, the S100A12, TIGIT, SERPINB2, GRB10 and LHFPL2 genes in peripheral serum have been identified as viable diagnostic biomarkers for depressive disorders, the first being the most valuable [20]. All five suggest changes in the immune system in clinical depression.…”